Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma

NCT00586846 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Osteosarcoma

Interventions

DRUG: Cisplatin
DRUG: Doxorubicin
DRUG: Methotrexate

Sponsor

Memorial Sloan Kettering Cancer Center